Heart health is the number one challenge in US healthcare
the most prevalent health issue1
the number one cause of death3
and the most expensive4
47%
of Americans have hypertension2
$9482
average annual medical costs for individuals with hypertension5
Heart health is the number one challenge in US healthcare
The Solution
We empower people to control their heart health on their own terms.Hello Heart is an easy, fun and
engaging way to lower your hypertension. Available through your employer health plan.
Trusted by leading U.S. employers and health plans
We have been using Hello Heart for over 4 years here at Delta, and our employees continue to tell us how much they love the program and how helpful it is.
Jae Kullar
Global Health & Wellbeing General Manager
We see strong clinical outcomes and are confident that we are achieving an ROI in this program.
Todd Smasal
VP, Talent & Total Rewards
Hello Heart made the implementation process very easy.
Kristen Bjorne
Director of Benefits, HR
Why hello heart
The proven, easy-to-implement program that employees love
On average, nearly 20% of target populations enroll in the first year, and 60% of users continue to use the Hello Heart app after one year.6
Proven results
Hello Heart offers 2X greater improvement than other digital heart health solutions7 and potential savings of $1,865 in total year 1 medical costs per participant.8
Easy to work with
We provide full-service enrollment campaigns, simplified billing, streamlined contracting via CVS Health and leading health plans, and integrations with your other healthcare and wellness benefits.
OUTCOMES
Peer-reviewed studies and claims data demonstrate unparalleled clinical and financial outcomes
The Hello Heart app is more than twice as effective as other leading digital heart health solutions.7
A 3-year study by UCSF and Hello Heart observed a 21mmHg average drop in systolic blood pressure after 3 years for users with baseline BP over 140/90.9
$1,865
potential cost savings
Cost savings analysis
A third-party analysis of employer claims data found avg. cost savings of $1,865 in year one medical costs per user compared to matched non-users.8
69%
normalized BP at 22 wks
Clinical Study
A Harvard Medical School and UCLA study found that 69% of users with baseline BP above 140/90 normalized their blood pressure at 22 weeks.10
IMPACT
Real users, real stories
Empower your members to improve their heart health while lowering your costs with the only digital health therapeutic focused exclusively on the heart.
Oops! Something went wrong while submitting the form.
By clicking submit, you agree to our friendly Privacy Policy
Footnotes
Reducing the Burden of Chronic Disease. Aspen Health Strategy Group. https://www.aspeninstitute.org/wp-content/uploads/2019/02/AHSG-Chronic-Disease-Report-2019.pdf. Published January 2019. Accessed May 23, 2022.
Facts About Hypertension. CDC Web site. https://www.cdc.gov/bloodpressure/facts.htm. Published September 27, 2021. Accessed May 23, 2022.
Ahmed FB, Anderson RN. The Leading Causes of Death in the US for 2020. JAMA. 2021;325(18):1829-1830. https://jamanetwork.com/journals/jama/fullarticle/2778234. Accessed May 23, 2022.
This includes heart disease and stroke, which are both related to heart health. Source: Schmidt H. Top 10 Most Expensive Chronic Diseases for Healthcare Payers. HealthPayerIntelligence. February 22, 2022. https://healthpayerintelligence.com/news/top-10-most-expensive-chronic-diseases-for-healthcare-payers. Accessed May 23, 2022.
Figure calculated as part of Validation Institute’s analysis of Hello Heart cost savings. Source: Validation Institute. 2021 Validation Report (Valid Through October 2022). https://validationinstitute.com/wp-content/uploads/2021/10/Hello_Heart-Savings-2021-Final.pdf. Published October 2021. Accessed May 23, 2022. (This analysis was commissioned by Hello Heart, which provided a summary report of self-funded employer client medical claims data for 203 Hello Heart users and 200 non-users from 2017-2020. Findings have not been subjected to peer review.)
Based on data on file at Hello Heart.
Sources: (1) Gazit T, Gutman M, Beatty AL. Assessment of Hypertension Control Among Adults Participating in a Mobile Technology Blood Pressure Self-management Program. JAMA Netw Open. 2021;4(10):e2127008, https://doi.org/10.1001/jamanetworkopen.2021.27008. Accessed May 23, 2022. (Some study authors are employed by Hello Heart. Because of the observational nature of the study, causal conclusions cannot be made. See additional important study limitations in the publication. This study showed that 108 participants with baseline blood pressure over 140/90 who had been enrolled in the program for 3 years and had application activity during weeks 148-163 were able to reduce their blood pressure by 21 mmHg using the Hello Heart program.) (2) Livongo Health, Inc. Form S-1 Registration Statement. https://www.sec.gov/Archives/edgar/data/1639225/000119312519185159/d731249ds1.htm. Published June 28, 2019. Accessed May 23, 2022. (In a pilot study that lasted six weeks, individuals starting with a blood pressure of greater than 140/90 mmHg, on average, had a 10 mmHG reduction.) NOTE: This comparison is not based on a head-to-head study, and the difference in results may be due in part to different study protocols.
Validation Institute. 2021 Validation Report (Valid Through October 2022). https://validationinstitute.com/wp-content/uploads/2021/10/Hello_Heart-Savings-2021-Final.pdf. Published October 2021. Accessed May 23, 2022. (This analysis was commissioned by Hello Heart, which provided a summary report of self-funded employer client medical claims data for 203 Hello Heart users and 200 non-users from 2017-2020. Findings have not been subjected to peer review.)
Gazit T, Gutman M, Beatty AL. Assessment of Hypertension Control Among Adults Participating in a Mobile Technology Blood Pressure Self-management Program. JAMA Netw Open. 2021;4(10):e2127008, https://doi.org/10.1001/jamanetworkopen.2021.27008. Accessed May 23, 2022. (Some study authors are employed by Hello Heart. Because of the observational nature of the study, causal conclusions cannot be made. See additional important study limitations in the publication.)
Kaplan AL, Cohen ER, Zimlichman E. Improving patient engagement in self-measured blood pressure monitoring using a mobile health technology. Health Inf Sci Syst. 2017; 5 (4). https://doi.org/10.1007/s13755-017-0026-9. Accessed May 23, 2022. (Because of the observational nature of the study, causal conclusions cannot be made. There were 783 participants with baseline systolic blood pressure ≥ 140. See additional important study limitations in the publication.)
.svg)
.svg)
.png)
.png)
.png)
%20(1).jpg)
.png){kind=small}
